Article: Genetic testing thorny for insurers. (privacy issue vs. the value of new information) (part 2)

Genetic Testing Thorny For Insurers

Advances in genetic research have created a unique paradox for insurers. On the one hand, new information is or will be available on a variety of genetic illnesses. But the costs of the tests as well as the potential public outcry over privacy issues make widespread screening a particularly thorny issue.

Debbie Chase, a spokesperson for the American Council of Life Insurance, admitted that a life industry is "somewhat defensive" after a series of stories in the popular press, prompted by the research of Dr. Paul Billings, formerly of the Harvard Medical School.

One case study, which has appeared frequently in ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!